CREATE Medicines
PrivateLast Round
Series B
May 14, 2026
Total Funding Raised
$245M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
CREATE Medicines is a clinical-stage biotechnology company that develops mRNA-based in vivo cell therapies for the treatment of cancer, autoimmunity, and fibrosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CREATE Medicines Comparables
Compare CREATE Medicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stylus Medicine | 86% | |
| Aera Therapeutics | 85% | |
| Alaya.bio | 84% | |
CREATE Medicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 14, 2026 | ||||
| Series A Extension | May 18, 2023 | ||||
| Series A | Jan 6, 2021 |
Key People
Founding team and executive leadership
CREATE Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Newpath Partners | Series B, Series A, Series A Extension |
| ARCH Venture Partners | Series A Extension, Series B |
| Hatteras Venture Partners | Series A, Series B, Series A Extension |
| Moore Strategic Ventures | Series A Extension |
| ARCH Venture Partners | Series A Extension |
| Alexandria Venture Investments | Series B, Series A Extension, Series A |
| Hatteras Investment Partners | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors increased 92% MoM.
- Jul 27, 2026
Grew 19% QoQ, from 37 to 44 employees.
CREATE Medicines Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CREATE Medicines's valuation, stock price, and market status.